Bill promotes use of cord blood stem cells in treating disease

摘要

A bipartisan quintet of senators has proposed a bill that would promote the use of stem cells derived from cord blood, or blood collected from the umbilical cord and placenta after childbirth, in treating disease. At an October 17 press conference, Sens. Orrin Hatch (R-Utah), Chris Dodd (D-Conn.), Sam Brownback (R-Kan.), Arlen Specter (R-Penn.), and Dianne Fe- instein (D-Calif.), who hold different views on controversial embryonic stem cell research, hailed what they called "a new commitment to developing a national infrastructure of cord blood stem cell collection and research that could, in time, save the lives of thousands of gravely ill Americans."